PEMBROLIZUMAB - INJECTION
PHONETIC PRONUNCIATION: (PEM-broe-LIZ-ue-mab)
COMMON BRAND NAME(S): Keytruda
GENERIC NAME(S): pembrolizumab
Uses
USES: Pembrolizumab is used to treat cancer. It works by changing the action of your own immune system, directing it to attack cancer cells. Pembrolizumab belongs to a class of drugs known as monoclonal antibodies.
How to use PEMBROLIZUMAB - INJECTION
HOW TO USE: Read the Medication Guide provided by your pharmacist before you start receiving pembrolizumab and each time you get a treatment. If you have any questions, ask your doctor or pharmacist. This medication is given by a health care professional. It is injected slowly into a vein over 30 minutes. It is given as directed by your doctor, usually once every 3 weeks. Symptoms of a severe infusion reaction that may occur during pembrolizumab treatment include fever, chills, shaking, flushing, trouble breathing, dizziness, or feeling faint. Tell your healthcare provider right away if you have any of these symptoms during your treatment. The dosage is based on your medical condition, weight, and response to treatment.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for PEMBROLIZUMAB - INJECTION
- Pembrolizumab injection is used to treat certain types of cancer, including melanoma, lung cancer, head and neck cancer, classical Hodgkin lymphoma, and urothelial carcinoma.
- Pembrolizumab is a type of immunotherapy that works by helping the body's immune system to find and attack cancer cells.
- Common side effects of Pembrolizumab injection may include fatigue, rash, itching, diarrhea, muscle or joint pain, nausea, and decreased appetite.
- Pembrolizumab is given as an intravenous (IV) infusion by a healthcare provider.
- The frequency of Pembrolizumab injections varies depending on the type of cancer being treated. It is typically given every 3 or 4 weeks.
- Yes, Pembrolizumab is often used in combination with other cancer treatments, such as chemotherapy or targeted therapy, to enhance its effectiveness.
- The duration of treatment with Pembrolizumab injection depends on the individual's response to the medication and the specific type of cancer being treated. It can range from a few months to several years.
- Pembrolizumab may not be suitable for individuals with certain autoimmune disorders, and it is important to inform your healthcare provider about any ongoing medical conditions or medications you are taking before starting treatment.
- Some individuals may experience long-term side effects with Pembrolizumab, such as thyroid problems, lung problems, or colitis. It is important to discuss any concerns with your healthcare provider.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet